October 17, 2023
Holland & Knight Health Dose: October 17, 2023
Holland & Knight Healthcare Blog
![Holland & Knight Health Dose](/-/media/images/twittercards/blogs/healthdose.png?rev=28e9e198d69c446c9fd8409f368b8252&sc_lang=en&hash=7A2FDB35CB2B5C08E70E64C1347FE915)
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include:
- This Week: Upcoming Hearings and Markups
- House Speaker Vote
- HELP Democrats Release Staff Report on Nonprofit Charity Care
- House GOP Doctors Caucus Releases Draft Legislation
- 340B-Related Increases Impact 2024 Medicare Parts A & B Premiums and Deductibles; Part D IRMAAs Announced
- FDA Forms Digital Health Advisory Committee
- ARPA-H Awards $26 Million to Address Transplant Shortages
- Paxlovid to Enter Commercial Market Under New HHS-Pfizer Agreement
- CMS Lifts National Coverage Determination Limiting Coverage of Amyloid PET Scans for Alzheimer's Disease
- Final Rule on Civil Money Penalties for Failure to Meet Medicare Secondary Payer Reporting Obligations